506128 Stock Overview
Parnax Lab Limited manufactures and sells pharmaceutical formulations in India.
Parnax Lab Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹99.20|
|52 Week High||₹169.90|
|52 Week Low||₹22.00|
|1 Month Change||11.09%|
|3 Month Change||-22.04%|
|1 Year Change||284.50%|
|3 Year Change||312.47%|
|5 Year Change||77.30%|
|Change since IPO||1,080.95%|
Recent News & Updates
|506128||IN Pharmaceuticals||IN Market|
Return vs Industry: 506128 exceeded the Indian Pharmaceuticals industry which returned -11.7% over the past year.
Return vs Market: 506128 exceeded the Indian Market which returned 9.1% over the past year.
|506128 Average Weekly Movement||9.0%|
|Pharmaceuticals Industry Average Movement||5.9%|
|Market Average Movement||6.3%|
|10% most volatile stocks in IN Market||9.0%|
|10% least volatile stocks in IN Market||4.1%|
Stable Share Price: 506128 is more volatile than 90% of Indian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: 506128's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. The company also provides cosmetic products; herbal/ayurvedic products; and nutraceutical products.
Parnax Lab Limited Fundamentals Summary
|506128 fundamental statistics|
Is 506128 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|506128 income statement (TTM)|
|Cost of Revenue||₹929.90m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||8.01|
|Net Profit Margin||5.38%|
How did 506128 perform over the long term?See historical performance and comparison